asia

WSPN and TradeGo Partner to Bring Global Commodity Trade and Stablecoin Settlements On-Chain Across Australia, Asia, and LATAM

TORTOLA, British Virgin Islands, Dec. 23, 2025 /PRNewswire/ -- Worldwide Stablecoin Payment Network (WSPN), a leading provider of next-generation stablecoin infrastructure,…

2 weeks ago

Velo Announces Integration of USD1 With World Liberty Financial to Strengthen PayFi Infrastructure Across Asia

SINGAPORE, Dec. 22, 2025 /PRNewswire/ -- Velo, a PayFi infrastructure protocol focused on real world financial adoption, today announced a strategic…

2 weeks ago

Startek Malaysia wins three HR Asia 2025 awards, reaffirming its people-first culture

Recognized for excellence in workplace culture, DEI and sustainabilityKUALA LUMPUR, Malaysia and DENVER, Dec. 17, 2025 /PRNewswire/ -- Startek®, a digital-first…

3 weeks ago

3 in 4 Asia Pacific Entrepreneurs Anticipate Economic Gains Next Year – Herbalife Survey

HONG KONG, Dec. 17, 2025 /PRNewswire/ -- Herbalife, a premier health and wellness company, community and platform, today released findings…

3 weeks ago

MEDEZE Receives Frost & Sullivan’s 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine

The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast AsiaSAN ANTONIO, Dec. 15, 2025 /PRNewswire/…

3 weeks ago

Manulife Financial Asia Limited Wins ACES Award 2025 for Top Sustainability Advocates in Asia

HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Manulife Financial Asia Limited has been named a winner of the Asia Corporate…

4 weeks ago

ORIC Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025

December 05, 2025 20:00 ET  | Source: ORIC Pharmaceuticals Highly differentiated 1L preliminary systemic activity of 67% ORR and 100%…

4 weeks ago

ORIC Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025

December 05, 2025 01:00 ET  | Source: ORIC Pharmaceuticals Systemic activity of 35% ORR in 2L+ patients, including in patients…

1 month ago

ZTE CDO Cui Li speaks at Economist Impact’s AI Innovation Asia 2025

SINGAPORE, Dec. 4, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology…

1 month ago

AppliedHE Launches First-Ever Asia Ranking to Recognise Both Public and Private Universities – with Student Voices at the Core

KUALA LUMPUR, Malaysia, Dec. 3, 2025 /PRNewswire/ -- AppliedHE today announced the results of the inaugural AppliedHE Public & Private…

1 month ago